BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7826898)

  • 1. Do we know the treatment of choice for hairy cell leukemia?
    Golomb HM
    Ann Oncol; 1994 Oct; 5(8):676-7. PubMed ID: 7826898
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal treatment for untreated patients with hairy cell leukemia?
    Troussard X; Flandrin G
    J Clin Oncol; 1995 Oct; 13(10):2677-9. PubMed ID: 7595722
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
    Pawelski S
    Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advances in the treatment of hairy cell leukemia.
    Andrey J; Saven A
    Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103
    [No Abstract]   [Full Text] [Related]  

  • 5. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon-alpha in the treatment of hairy cell leukemia. New perspectives].
    Flandrin G
    Presse Med; 1993 Jan 2-16; 22(1):9-12. PubMed ID: 8097039
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer purine analogues for the treatment of hairy-cell leukemia.
    Saven A; Piro L
    N Engl J Med; 1994 Mar; 330(10):691-7. PubMed ID: 7906385
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
    Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
    J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hairy cell leukemia: therapeutic approaches].
    Paitel JF; Guerci A; Lederlin P
    Rev Med Interne; 1996; 17(5):399-406. PubMed ID: 8763100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine in the treatment of hairy-cell leukaemia.
    Goodman GR; Beutler E; Saven A
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):101-16. PubMed ID: 12670469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha is a very effective salvage therapy for patients with hairy cell leukemia relapsing after cladribine: a report of three cases.
    Hoffman MA
    Med Oncol; 2011 Dec; 28(4):1537-41. PubMed ID: 20509009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent somatic mutation in hairy cell leukemia].
    Sári E; Nagy Z; Demeter J
    Orv Hetil; 2013 Jan; 154(4):123-7. PubMed ID: 23335721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia.
    Ganeshaguru K; de Mel WC; Sissolak G; Catovsky D; Dearden CE; Mehta AB; Hoffbrand AV
    Adv Exp Med Biol; 1991; 309A():65-8. PubMed ID: 1789272
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.